Following her recent visit to LDI:REACH programme facilities in India and Bangladesh, Dr Alison Wright reflects on how empowering frontline OBGYNs to identify challenges and lead change is improving maternal and newborn care and delivering meaningful outcomes, often in difficult circumstances.
The Société des Gynécologues Obstétriciens du Togo (SGOT) recently became the 13th FIGO member society to join as a direct implementing partner in the Advocating for Safe Abortion (ASA) project. It was launched in Lomé with a three day workshop on advocacy strategies and the creation of an action plan for 2025.
Nominations are now open for the positions of Officer Trustees, Regional Trustees and the FIGO Council for the 2025–2027 term. You can find more information on the independent Mi-Voice platform. Submit your nomination by 23.59 UTC on 5 June 2025.
Nominate your colleagues for the FIGO Women’s Awards 2025
Nominate female leaders in obstetrics and gynaecology who have made a global impact on women’s health for the FIGO Women’s Awards 2025. The deadline is 23.59 UTC on 14 May.
Join us on Thursday 8 May 2025 for our next webinar: Closing the obstetric fistula treatment gap. Hear from leading fistula surgeons and advocates as they discuss this devastating childbirth injury within the African context and learn how FIGO’s Fistula Surgery Training Initiative is helping to address the global shortage of fistula specialists.
Apply for the prestigious FIGO and Chien-Tien Hsu Fellowship in gynaecologic oncology for the opportunity to travel to Cape Town to attend a centre of excellence and the 2025 FIGO World Congress. If you have an accepted abstract or a pending late-breaking abstract, you may be eligible. Applications close at 23.59 UTC on 30 April.
Our new bursary programme helps researchers, particularly from low-income countries, attend our World Congress. If you have an accepted abstract or pending late-breaking abstract you may be eligible. Applications close at 23.59 UTC on 30 April.
Help us learn more about the use of tranexamic acid in your country
Support our AMPLI-PPH project by completing a short survey about the supply and use of tranexamic acid (TXA) as part of the treatment for postpartum haemorrhage (PPH). We have extended the response deadline and would greatly value your input by 23:59 UTC on 30 April.
You are receiving this newsletter in English because this is the preferred FIGO official language we have on record for you. If you would prefer to receive it in French or Spanish, please email membership@figo.org to let us know.
